Biomea Fusion

Filed a patent for "pyrazine compounds as irreversible inhibitors of flt3" on Tue, February 20, 2024

Filed a patent for "crystalline forms of a covalent inhibitor of menin-mll interaction" on Wed, January 18, 2023

Filed a patent for "crystalline forms of a covalent inhibitor of menin-mll interaction" on Tue, February 7, 2023

Filed a patent for "crystalline forms of a covalent inhibitor of menin-mll interaction" on Wed, February 22, 2023

Filed a patent for "crystalline forms of a covalent inhibitor of menin-mll interaction" on Mon, March 27, 2023

Filed a patent for "fused pyrimidine compounds as inhibitors of menin" on Thu, July 27, 2023

Filed a patent for "crystalline forms of a covalent inhibitor of menin-mll interaction" on Wed, August 30, 2023

Filed a patent for "fused pyrimidine compounds as inhibitors of menin" on Wed, December 6, 2023

Filed a patent for "crystalline forms of an irreversible inhibitor of menin-mll interaction" on Thu, October 17, 2024

Filed a patent for "inhibitors of kras" on Fri, March 8, 2024

Filed a patent for "irreversible inhibitors of kras" on Mon, March 11, 2024

Filed a patent for "pyrazine compounds as inhibitors of flt3" on Thu, August 8, 2024

Filed a patent for "covalent inhibitors of menin-mll interaction for diabetes mellitus" on Thu, April 20, 2023

Filed a patent for "crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-mll interaction" on Thu, March 23, 2023

Filed a patent for "inhibitors of kras" on Mon, September 19, 2022

Filed a patent for "pyrazine compounds as inhibitors of flt3" on Fri, December 9, 2022

Filed a patent for "pyrazine compounds as inhibitors of flt3" on Thu, October 26, 2023

Filed a patent for "irreversible inhibitors of menin-mll interaction" on Thu, July 20, 2023

Filed a patent for "fused pyrimidine compounds as inhibitors of menin" on Fri, June 2, 2023

Filed a patent for "fused pyrimidine compounds as inhibitors of menin-mll interaction" on Thu, April 18, 2024

Filed a patent for "substituted pyridines as irreversible inhibitors of menin-mll interaction" on Thu, December 7, 2023

Filed a patent for "inhibitors of menin-mll interaction" on Thu, May 2, 2024

Filed a patent for "flt combination therapy for cancer and compositions therefor" on Tue, May 17, 2022

Filed a patent for "substituted pyrazine compounds as irreversible inhibitors of flt3" on Tue, May 17, 2022

Filed a patent for "fused pyrimidine compounds as inhibitors of menin-mll interaction" on Fri, June 3, 2022